|
Daily Tofacitinib Beneficial in Rheumatoid Arthritis
|
Tofacitinib is a safe and effective combination therapy for patients with active rheumatoid arthritis who do not achieve adequate responses with methotrexate, according to new study results.
|
|
Read more
|
|
|
|
Low Risk of Venous Thromboembolism with Tofacitinib
|
|
The JAK inhibitor tofacitinib presents a comparably low risk of venous thromboembolism to rheumatoid arthritis patients as do TNFi inhibitors, according to a new study.
|
|
Read more
|
|
|
|
MORE FROM RHEUMATOLOGY NETWORK
|
|
|
|
Tofacitinib and Cardiovascular Events
|
|
8 treatment recommendations for PsA
|
|
5 Qs About RA Management: A Quiz
|
|
Overall Well-Being In RA Achieved With Tofacitinib
|
